Belimumab, Azathioprine Did Not Lower Risk for Relapse in ANCA-Associated Vasculitis
Belimumab in combination with glucocorticoids and azathioprine did not lower the risk for relapse in patients with antineutrophil cytoplasm antibody-associated vasculitis.